Harry Boxer
The Technical Trader
The stock market indices had a turnaround Tuesday as they rolled over and took a big loss off of clear, overhead resistance, which they failed to get through at Nasdaq 100 4300 area. The S&P 500 had a big problem at the 1950 area, and as a result, they tanked today, coming down on really hard, and declining channels all day. There was a bounce in the last hour but it was a little anemic.
Net on the day, the Dow was down 295.64 at 16,153.54, 45 points off the low. The S&P 500 was down 36.35 to 1903.03, 6 points off its low. The Nasdaq 100 was down 93.46 to 4193.10, 13 points off its low.
Advance-declines were 4 to 1 negative on New York Stock Exchange and 4 1/ to 1 negative on Nasdaq. Up/down volume was 7 to 1 negative on New York, with total volume of 4.4 billion shares traded. The Nasdaq traded 2.15 billion shares and had a 6 to 1 negative volume ratio.
TheTechTrader.com board had the majority of big losses. Priceline Inc. (PCLN) was down 18.08 to 1066.79, Apple Inc. (AAPL) down 1.95 to 94.48, Amazon.com Inc. (AMZN) down 22.71 to 552.10, and Netflix, Inc. (NFLX) down 2.60 to 91.49. Google Inc. (GOOG) was the only standout today, up 12.65 to 764.75, way off the high at 789.87, and is trading 60 points from its overnight high. Still, it was a 12-point gain.
Tesla Motors, Inc. (TSLA) lost 14.16 to 182.78, and Baidu, Inc. (BIDU) gave back 6.28 to 154.82. Facebook, Inc. (FB) was down just 48 cents to 114.61, Intel Corportation (INTC) closed down 1.02 to 29.80, and Microsoft Corporation (MSFT) fell 1.71 to 53.00.
In addition, Intra-Cellular Therapies, Inc. (ITCI) was down 3.68 to 32.57 in a very weak biotech sector, First Solar, Inc. (FSLR) down 3.00 to 66.13 in a weak solar sector, Bristol-Myers Squibb Company (BMY) down 1.95 to 58.87, and Mobileye N.V. (MBLY) 2.55 to 26.15.
The Direxion Daily Energy Bull 3X ETF (ERX) dropped 1.88 to 17.14.
Checking the TheTechTrader.com percent-gain leaderboard, Hansen Medical, Inc. (HNSN) popped to 5.10 before pulling back and closing up 31 cents to 3.51, or 10%, on 8.4 million shares. Vascular Biogenics Ltd. (VBLT) gained 55 cents to 3.35, or 20%, on 1.5 million shares.
Michael Kors Holdings Limited (KORS) ran 9.67 to 50.11, or 24%, on 28.4 million shares on a strong earnings report. Pacific Biosciences of California, Inc. (PACB) went along pretty smooth all day, until about 3 PM when it had a late surge on a potential takeover, going straight up to 13.98, bounced around and closed up 2.48 to 12.67, or 24%, on 8.4 million shares. Mattel, Inc. (MAT), one of our swing trades, advanced 3.70 to 30.46, or 14%, on 28 million shares, on a strong report.
The VelocityShares 3x Inv Natural Gas ETN (DGAZ) gained 2.08 to 16.55, or 14%, on 7.2 million shares. The Direxion Daily Russia Bear 3X ETF (RUSS) popped 5.49 to 42.65, or 15%. The ProShares Ultra VIX Short-Term Futures (UVXY) climbed 4.89 to 42.43, or 13%, on 29 million shares. The VelocityShares Daily 2x VIX ST ETN (TVIX) bounced 1.08 to 9.32, or 13%, on 38.7 million shares. The Direxion Daily S&P Biotech Bear 3X ETF (LABD) rose 7.55 to 76.98, or 11%.
Stepping back and reviewing the hourly chart patterns, the indices opened sharply lower, bounced to the bear flag in the morning, rolled over again, and stair-stepped its way lower in a 5-wave decline that ended badly.
Let's see what happens tomorrow. Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
AUD/USD remained bid above 0.6500
AUD/USD extended further its bullish performance, advancing for the fourth session in a row on Thursday, although a sustainable breakout of the key 200-day SMA at 0.6526 still remain elusive.
EUR/USD faces a minor resistance near at 1.0750
EUR/USD quickly left behind Wednesday’s small downtick and resumed its uptrend north of 1.0700 the figure, always on the back of the persistent sell-off in the US Dollar ahead of key PCE data on Friday.
Gold holds around $2,330 after dismal US data
Gold fell below $2,320 in the early American session as US yields shot higher after the data showed a significant increase in the US GDP price deflator in Q1. With safe-haven flows dominating the markets, however, XAU/USD reversed its direction and rose above $2,340.
Bitcoin price continues to get rejected from $65K resistance as SEC delays decision on spot BTC ETF options
Bitcoin (BTC) price has markets in disarray, provoking a broader market crash as it slumped to the $62,000 range on Thursday. Meanwhile, reverberations from spot BTC exchange-traded funds (ETFs) continue to influence the market.
US economy: slower growth with stronger inflation
The dollar strengthened, and stocks fell after statistical data from the US. The focus was on the preliminary estimate of GDP for the first quarter. Annualised quarterly growth came in at just 1.6%, down from the 2.5% and 3.4% previously forecast.